Clinical trial Recruiting at 1 site Interventional Ages 21 and up

How a very-low-nicotine cigarette standard and product prices affect illegal cigarette buying

Official title: Effects of a Low Nicotine Standard and Tobacco Prices on Illegal Cigarette Purchasing

Run by Virginia Polytechnic Institute and State University · NCT07161050 · Data updated 2026-11-12

This study will test whether requiring very-low-nicotine cigarettes and changing e-cigarette or illegal cigarette prices changes illegal cigarette buying and use of alternatives among adult smokers and dual users.

Quick facts

Study typeInterventional
Ages21 Years and up
SexAll
Enrollment70 (estimated)
SponsorVirginia Polytechnic Institute and State University
Academic / other
Locations1 site (Roanoke, Virginia)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedOctober 1, 2026
Study endsOctober 7, 2026
Registry record updatedJanuary 16, 2026
Trial IDNCT07161050 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 21 or older who smoke at least 10 cigarettes per day and are either exclusive smokers or regular dual users of cigarettes and nicotine vaping products, and who can attend three in-person sessions, are the intended participants.

Probably not a fit

People who are pregnant or lactating, planning to quit immediately, have unstable medical or psychiatric conditions, or are taking medications that affect nicotine metabolism are excluded and unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will bring adult exclusive cigarette smokers and dual cigarette/vaping users into a lab to complete an experimental virtual marketplace where legal and illegal product availability and prices are varied. Participants will complete three sessions (screening/assessment, the experimental tobacco marketplace session, and a follow-up phone call) and encounter scenarios comparing normal-nicotine and very-low-nicotine legal conditions. The experiment manipulates three levels of e-cigarette price and three levels of illegal cigarette price to see how those factors influence purchasing of illegal products and alternative nicotine product use. Outcomes will include choices made in the marketplace under each condition and differences by smoking/vaping status and age strata.

Why it matters

Potential benefit: If successful, the results could help regulators design nicotine standards and pricing policies that reduce harmful smoking while minimizing shifts to illegal cigarette markets.

How similar studies have gone: Previous laboratory and experimental marketplace studies of very-low-nicotine cigarettes and price changes have shown reductions in cigarette use, but effects specifically on illegal cigarette purchasing are less well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Provide informed consent Be at least 21 years of age or older Provide a breath sample for measuring carbon monoxide (CO ≥ 8 ppm) Stable tobacco use patterns for at least two months

Exclusion Criteria:

For exclusive cigarette smokers:

Smoke at least 10 cigarettes daily and do not use NVPs regularly (no more than 9 times in the last month).

For dual cigarette/NVP users:

Smoke at least 10 cigarettes daily and use NVPs at least 3 times in a week (report use of closed nicotine salt system)

For both groups:

Have plans to move out of the area Have a serious or unstable physical or mental health condition Taking a tobacco cessation medication or medication that interferes with nicotine metabolism, motivation or reinforcement Report concrete, immediate plans to alter/quit using their usual nicotine products at the beginning of the study Being pregnant or lactating

Where it's running

  • Fralin Biomedical Research Institute at Virginia Tech Carilion
    Roanoke, Virginia, United States
    Recruiting

Study contacts

  • Principal investigator: Roberta Freitas-Lemos, PhD — Fralin Biomedical Research Institute at Virginia Tech Carilion
  • Study coordinator: Kirstin Gatchalian
  • Email: kmgatch@vtc.vt.edu
  • Phone: 540-526-2071

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.